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Abstract: In synaptosomal membranes from rat brain cortex, 
in the presence of 150 m M  NaCI, the opioid antagonist 
[3H]naltrexone bound to two populations of receptor sites 
with affinities of 0.27 and 4.3 nM, respectively, Guanosine- 
5’-(3-thiotriphosphate) had little modulating effect and did 
not alter the biphasic nature of ligand binding. On the other 
hand, receptor-selective opioids differentially inhibited the 
two binding components of [3H]naltrexone. As shown by 
nonlinear least-squares analysis, the p opioids Tyr-D-Ala- 
Gly-(Me)Phe-Gly-ol or sufentanil abolished high-affinity 
[3H]naltrexone binding, whereas the &selective ligands [D- 
Pen*,~-Pen’]enkephalin, ICI 174,864, and oxymorphindole 
inhibited and eventually eliminated the low-affinity com- 
ponent in a concentration-dependent manner. These results 
indicate that, in contrast to the guanine nucleotide-sensitive 
biphasic binding of opioid-alkaloid agonists, the heterogeneity 
of naltrexone binding in brain membranes reflects ligand in- 
teraction with different opioid-receptor types. Key Words: 
Opioid receptors-Agonist-antagonist binding-p- and 6-se- 
lective ~pioids-[~H]Naltrexone-Rat brain cortex. Rem- 
mers A. E. and Medzihradsky F. Resolution of biphasic 
binding of the opioid antagonist naltrexone in brain mem- 
branes. J. Neurochem. 57, 1265-1269 (1991). 
In interacting with their receptors, opioid alkaloids, 
both agonists and antagonists, display characteristic 
biphasic binding. In rat brain membranes, high- and 
low-affinity binding components were described for the 
agonists dihydromorphine (Childers and Snyder, 1980), 
sufentanil (Leysen et al., 1983), and etorphine (Fischel 
and Medzihradsky, 1986), and for the antagonists nal- 
oxone (Childers and Snyder, 1980) and naltrexone 
(Fischel and Medzihradsky, 198 1). Heterogeneity in 
the dissociation of bound [3H]naltrexone (Fischel and 
Medzihradsky, 1981) and [3H]naloxone (Sziics et al., 
1987) has also been reported. After various interpre- 
tations of these findings, it was recently shown that the 
biphasic binding of [3H]dihydromorphine, but not 
[3H]naltrexone, reflects different association states of 
the agonist-occupied opioid receptor with G protein 
(Remmers and Medzihradsky, 199 1). Considering the 
results of the latter study, which included evidence for 
lacking modulation of antagonist binding by guanine 
nucleotides also described previously (e.g., Blume, 
1978), we have in this work investigated the interaction 
of [3H]naltrexone with multiple opioid receptors as the 
underlying mechanism for the heterogeneity of its re- 
ceptor binding. Initially, we have identified highly se- 
lective p and 6 opioids suitable to resolve ligand binding 
to multiple opioid receptors (Clark et al., 1988). The 
obtained results indicate that, in synaptosomal mem- 
branes from rat brain cortex, the biphasic binding of 
[3H]naltrexone reflects its interaction with both p- and 
8-opioid receptors. 
MATERIALS AND METHODS 
Materials 
[3H]Naltrexone was kindly provided by the National In- 
stitute on Drug Abuse. Tyr-D-Ala-Gly-(Me)Phe-Gly-ol 
(DAMGO) was purchased from Peninsula Laboratories and 
guanosine-5’-(3-thiotriphosphate)-tetralithium salt (GTP-y- 
S) from Boehringer-Mannheim Biochemicals. The p- and 6- 
selective opioids sufentanil, DAMGO, [D-Pen2,D-Pen5]- 
enkephalin (DPDPE), ICI 174,864 (Clark et al., 1988), and 
oxymorphindole (Woods et al., 1990) were obtained through 
the Opioid Basic Research Center at the University of Mich- 
igan. 
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Membrane preparation 
Synaptosomal membranes from brain cortices of adult 
male Sprague-Dawley rats were prepared as described pre- 
viously (Cahill and Medzihradsky, 1976). Aliquots of the 
membrane suspension, at a protein concentration of 1 mg/ 
ml, were stored at -70°C. Protein was determined according 
to Bradford (1976), using bovine serum albumin as the stan- 
dard. 
Opioid-receptor binding 
Equilibrium binding of [3H]naltrexone was reached in 30 
min, and was performed at 25°C as described previously 
(Fischel and Medzihradsky, 1981). The assay medium con- 
sisted of 400 pl of membrane suspension in 50 mM Tris- 
HCl, pH 7.4, 50 p1 of NaCl to give a final concentration of 
150 mM, 50 pl of a solution of unlabeled opioid, and 25 p1 
of ['Hlnaltrexone solution. Specific ligand binding was de- 
fined as the difference between ['Hlnaltrexone bound in the 
absence and presence of I pLMunlabeled naltrexone. In some 
experiments, 5 pM GTP--y-S was included in the assay me- 
dium. In all experiments with competing opioids, the mem- 
branes were first incubated for 15 min at 25°C with the un- 
labeled ligand and 150 mM NaC1, followed by the incubation 
with ['Hlnaltrexone to reach equilibrium. 
Data analysis 
For the statistical evaluation of ligand binding, the NON- 
LIN module in the computer program SYSTAT was used as 
described (Remmers et al., 1990). This generalized nonlinear 
least-squares regression program was applied to fit the data 
to a two- or one-site binding model. After the initial regres- 
sion, the residuals were displayed in a normal probability 
plot, using the GRAPH module of SYSTAT, to evaluate both 
their magnitude and departure from expected normally dis- 
tributed residuals. All data reported are based on regressions 
for which the distribution of residuals was not different from 
a normal distribution. The corresponding standard error of 
the mean (SEM) was computed within NONLIN from the 
residual sum of squares (RSS) of the regression. 
RESULTS 
Scatchard analysis of [3H]naltrexone binding in the 
presence of 150 m M  NaCl revealed two populations 
of saturable binding sites with KDs of 0.27 and 4.3 nM, 
respectively. In contrast to the strong modulation of 
opioid-agonist binding by guanine nucleotides (Blume, 
1978; Childers and Snyder, 1980; Remmers and Med- 
zihradsky, 1991), GTP-7-S did not alter the binding 
of [3H]naltrexone (Fig. 1, inset). 
To test the hypothesis that high- and low-affinity 
naltrexone binding reflect interaction of the antagonist 
with the p- and 6-opioid receptor, respectively, the dis- 
placement of0.5 and 10 nM[3H]naltrexone (to saturate 
the low-affinity binding sites) by different concentra- 
tions of p- and &selective opioids was performed. We 
have previously shown that the p/6 selectivity indices 
(ratio of ECSOs in displacing tritiated DAMGO and 
DPDPE, respectively) for DPDPE, ICI 174,864, and 
oxymorphindole were 1,200, 998 (Clark et al., 1988), 
and 320 (Woods et al., 1990), respectively, whereas for 
200 :r 100 0 8 # BolMD I c 
" 
0 100 200 300 
PHI  NALTREXONE BOUND (fmol/mgl 
FIG. 1. Scatchard plots of [3H]naltrexone binding in the absence 
and presence of GTP-7-S and of pselective opioids. Equilibrium 
binding of [3H]naltrexone was performed in synaptosomal mem- 
branes in the presence of 150 mM NaCl and in the absence (0) 
and presence of 25 nM sufentanil(0) or 1 pM DAMGO (0). Plotted 
are results from representative experiments replicated at least three 
times. The corresponding binding parameters and statistical in- 
formation are listed in Table 1. Shown in the inset is the binding 
of [3H]naltrexone in the absence (0) and presence (0) of 5 pM 
GTP-y-S, both in the presence of 150 mM NaCI. The respective 
binding constants without and with (in parentheses) GTP-y-S were 
as follows: KO,,  0.36 (0.38) nM, K,, , 5.8 (6.0) nM, B,., , 177 (1 77) 
fmol/mg of protein, and B,, , 135 (1 49) fmol/mg of protein. These 
values represent the mean of 82 individual data points obtained 
in three experiments. 
DAMGO and sufentanil, they were 0.02 and 0.03 
(Clark et al., 1988). The high binding selectivities of 
DAMGO, sufentanil, and DPDPE were also described 
by the approach of site-directed alkylation of opioid 
receptors (James and Goldstein, 1984). The interaction 
between naltrexone and K receptors in the membrane 
preparation used was marginal: residual binding of 10 
nM t3H]naltrexone in the presence of sufentanil and 
oxymorphindole represented 4% of total binding. Fur- 
thermore, the K-selective opioid agonist U69,593 in- 
hibited the binding of 0.5 nM [3H]naltrexone in the 
presence of 150 mM NaCl with an ECS0 of > 10 pA4. 
Previously, the limited density of sites labeled by 
[3H]U69,583 has prevented the use of rat brain mem- 
branes to  investigate the interaction of opioids with K 
receptors in routine assays (Clark et al., 1988). Thus, 
based on the binding selectivity and on initial displace- 
ment experiments, 50 nM oxymorphindole, 2 pM 
DPDPE, or 2 pA4 ICI 174,864 were selected to  inhibit 
the low-affinity, putative 6 binding of [3H]naltrexone. 
On the other hand, 25 nM sufentanil and 1 pA4 
DAMGO were chosen to block the high-affinity, pu- 
tative p component of the antagonist. 
In contrast to  the remarkably similar biphasic bind- 
ing in the absence and presence of GTP-./-S (Fig. 1, 
inset), nonlinear least-squares analysis of [ 3H]nal- 
trexone binding in the presence of competing p or 6 
ligands revealed a single population of binding sites. 
In the presence of p opioids, the high-affinity 
[3H]naltrexone component was abolished and the KD 
of remaining binding sites was not significantly different 
from that displayed by low-affinity antagonist binding 
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1.27 (0.07)' ND 189 (8) ND 51 
0.77 (0.02)" ND 201 (3)" ND 57 
0.55 (0.17)' ND 210 (4)a ND 62 
Equilibrium-binding experiments were performed in the presence 
of 150 mM NaCI. Results of at least three experiments, with a total 
of n observations, were pooled and fitted to one- and two-site binding 
models as described in Materials and Methods. Shown are the binding 
parameters (SEM in parentheses) that best fit the data as determined 
by the residual sum of squares. ND, not detectable. 
Values that are different from respective controls at the 5% level 
of significance. 
in the absence of inhibitors (Fig. 1 and Table 1). In 
contrast, selective 6 opioids eliminated the low-affinity 
binding component of [3H]naltrexone (Figs. 2, 3;  Ta- 
ble 1). 
As illustrated for the displacement by ICI 174,864 
(Fig. 3) ,  the affinity of the remaining uninhibited bind- 
ing component was dependent on the concentration 
of displacing opioid used: in the presence of 2 and 10 
yM ICI 1 74,864, the KD of [3H]naltrexone binding in- 
creased to 0.5 and 0.7 nM, respectively, from 0.3 nM 
obtained in the absence of competing ligand (Table 1). 
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FIG. 2. Scatchard plots of [3H]naltrexone binding in the absence 
and presence of &selective opioids. Equilibrium binding of 
[3H]naltrexone in synaptosomal membranes was performed in the 
presence of 150 mM NaCl and in the absence (0) and presence 
of 50 nM oxymorphindole (W) or 2 pM DPDPE (e). Shown are 
results of a representative experiment replicated three times. The 
corresponding binding parameters and statistical information are 
listed in Table 1 .  
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FIG. 3. Resolution of r3Hlnaltrexone bindina bv different c ncen- - -  
trations of a &selective opioid. Equilibrium binding of [3H]naltrexone 
in synaptosomal membranes was performed in the presence of 
150 mM NaCl and in the absence (0) and presence (A) of ICI 
174,864 at concentrations as indicated. Shown in the inset is the 
computed relationship between the KO of [3H]naltrexone binding 
at the p receptor and the added concentration of the 6 opioid. The 
corresponding KD values are listed in Table 1 .  Plotted are the results 
of representative experiments replicated three times. 
Considering the interdependence of binding parameters 
in statistical analysis, constraining the numerical values 
of B,,, or KD frequently improves the resolution of 
binding data (Clark et al., 1989). Indeed, by keeping 
high-affinity antagonist binding in the absence and 
presence of 2 yM ICI 174,864 at the set value of 180 
fmol/mg of protein, the corresponding KDs were 0.3 
nM (control) and 0.4 nM (presence of displacer), in- 
dicating that with decreasing concentration of displac- 
ing ligand, the binding affinity of the nontargeted sites 
approaches that of the control (Fig. 3,  inset). It should 
be mentioned that in the presence of 2 yLM ICI 174,864, 
the equilibrium binding of the opioid agonist 
[3H]dihydromorphine retained its biphasic nature 
(A. E. Remmers and F. Medzihradsky, unpublished 
data). 
DISCUSSION 
We have recently described the reconstitution of 
high-affinity opioid-agonist binding in brain mem- 
branes (Remmers and Medzihradsky, 199 1). After in- 
activation of G proteins by alkali treatment, the high- 
affinity, GTP-sensitive component of [3H]dihydro- 
morphine was abolished. It was restored by fusing the 
synaptosomal membranes with membranes from 
opioid receptor-deficient but G protein-containing C6 
glioma cells. In contrast to that of the agonist, 
[3H]naltrexone binding was not influenced by the 
elimination or readdition of G proteins. In the present 
study, performed in the presence of sodium to convert 
the receptor into the antagonist conformation, GTP- 
7-S had no effect on [3H]naltrexone binding. Rather, 
the results indicate that the biphasic binding of 
[3H]naltrexone in synaptosomal membranes from rat 
brain cortex reflects interactions with y- and 6-opioid 
receptors. Highly selective p- and 6-opioid ligands 
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preferentially inhibited and, at appropriate concentra- 
tions, eliminated the high- and low-affinity binding 
components, respectively, of [3H]naltrexone. These re- 
sults are in line with the limited selectivity of 
[3H]naltrexone binding (Gillan et al., 1980) and with 
the heterogeneity of its dissociation from receptor 
(Fischel and Medzihradsky, 198 1). 
The displacement by p and 6 opioids accounted for 
both binding components of [3H]naltrexone. Attempts 
to also implicate the K receptors, by investigating the 
interactions of naltrexone and U69,593, were unsuc- 
cessful. Using quantitative autoradiography, the rela- 
tive densities of p, 6, and K receptors in the neocortex 
of rat brain were determined to be 42, 59, and 19%, 
respectively (Tempe1 and Zukin, 1987). In that study, 
[3H]ethylketocyclazocine was used as a K-selective li- 
gand together with DAMGO and [D-Ala2,D-Leu5]- 
enkephalin (DADLE) to block binding to K and 6 sites, 
respectively. Considering the marginal selectivity of 
DADLE as a 6 opioid (James and Goldstein, 1984), 
the protection against [3H]ethylketocyclazocine bind- 
ing to 6 receptors might have been inadequate. As de- 
termined by binding of receptor-selective opioids, the 
density of K sites in rat brain comprised only 12% of 
the sum of p-, 6-, and K-binding sites (Gillan and Kos- 
terlitz, 1982). In our study, the presence of K sites not 
saturated by 20 nM [3H]naltrexone, or of K sites not 
specific for U69,593, was not investigated. 
Optimal resolution of [3H]naltrexone binding, that 
is, the complete elimination of either of its two binding 
components was dependent on the use of the inhibitory 
ligands at an appropriate excess. Whereas in the pres- 
ence of insufficient ligand biphasic binding was main- 
tained, with rising concentrations the displacing opioid 
increasingly interacted with the other, nonselective re- 
ceptor sites. It has been previously shown that biphasic 
Scatchard plots of nonselective opioids such as the 6/ 
p agonist DADLE became linear in the presence of 
selective ligands that blocked access to one of the avail- 
able receptor populations (Gillan and Kosterlitz, 1982; 
Werling et al., 1985). A specific relationship between 
p and 6 sites existing on the same receptor complex 
has been proposed earlier by Rothman et al. (1985): 
the occupancy of the low-affinity 6 sites noncompeti- 
tively inhibited ligand binding to the high-affinity p 
sites. However, under the experimental conditions of 
that study (ammonium acetate buffer, pH 7.7, 4"C), 
[3H]naloxone bound to p and K but not 6 sites in rat 
brain membranes. On the other hand, high-affinity 
naloxone binding to 6 receptors in brain membranes 
from rat and guinea pig at 25°C has convincingly been 
demonstrated (Gillan et al., 1980; James and Goldstein, 
1984; Clark et al., 1988). 
Together with the reconstitution of high-affinity ag- 
onist binding with G protein (Remmers and Medzih- 
radsky, 199 l), the results presented here provide a mo- 
lecular basis for the heterogeneity in the binding of 
opioid agonists and antagonists. The described reso- 
lution of [3H]naltrexone binding corroborates the con- 
clusion reached in a recently completed study on the 
modulation of opioid receptors in brain membranes 
by fatty acids (Remmers et al., 1990). These com- 
pounds preferentially inhibited the binding of 6-selec- 
tive agonists and the low-affinity binding component 
of [3H]naltrexone. The results ofthe present study sup- 
port the view that the effect of the fatty acids reflects 
the targeting of the 6 receptor localized in a cationic 
membrane environment (Schwyzer, 1986). Notwith- 
standing the now accomplished characterization of 
opioid-ligand binding, additional studies are needed to 
clarify the different binding properties (biphasic and 
monophasic binding components, respectively) of 
opioid alkaloids and peptides of identical receptor se- 
lectivity (e.g., Ward et al., 1986). 
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